Literature DB >> 35039324

Attenuated response to fourth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series.

Mayan Teles1, Caoilfhionn M Connolly2, Sarah Frey3, Teresa Po-Yu Chiang3, Jennifer L Alejo3, Brian J Boyarsky1, Ami A Shah2, Jemima Albayda2, Lisa Christopher-Stine2, William A Werbel4, Dorry L Segev5,6, Julie J Paik2.   

Abstract

Entities:  

Keywords:  Covid-19; autoimmune diseases; epidemiology; vaccination

Mesh：

Substances：

Year:  2022        PMID： 35039324      PMCID： PMC8995356          DOI： 10.1136/annrheumdis-2021-221641

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response.

Authors:  Fredrik N Albach; Gerd R Burmester; Robert Biesen
Journal:  Ann Rheum Dis       Date:  2021-06-24       Impact factor: 19.103

2.  Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series.

Authors:  Caoilfhionn M Connolly; Teresa Po-Yu Chiang; Brian J Boyarsky; Jake A Ruddy; Mayan Teles; Jennifer L Alejo; Allan Massie; William A Werbel; Ami A Shah; Lisa Christopher-Stine; Jacqueline Garonzik-Wang; Dorry L Segev; Julie J Paik
Journal:  Ann Rheum Dis       Date:  2021-09-23       Impact factor: 19.103

3.  Booster-dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series.

Authors:  Caoilfhionn M Connolly; Mayan Teles; Sarah Frey; Brian J Boyarsky; Jennifer L Alejo; William A Werbel; Jemima Albayda; Lisa Christopher-Stine; Jacqueline Garonzik-Wang; Dorry L Segev; Julie J Paik
Journal:  Ann Rheum Dis       Date:  2021-09-07       Impact factor: 19.103

4.  High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases.

Authors:  Jake A Ruddy; Caoilfhionn Marie Connolly; Brian J Boyarsky; William A Werbel; Lisa Christopher-Stine; Jacqueline Garonzik-Wang; Dorry L Segev; Julie J Paik
Journal:  Ann Rheum Dis       Date:  2021-05-24       Impact factor: 19.103

5.  Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation.

Authors:  Victoria Higgins; Anselmo Fabros; Vathany Kulasingam
Journal:  J Clin Microbiol       Date:  2021-03-19       Impact factor: 5.948

6.  Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.

Authors:  Jennifer L Alejo; Jonathan Mitchell; Teresa P-Y Chiang; Aura T Abedon; Brian J Boyarsky; Robin K Avery; Aaron A R Tobian; Macey L Levan; Allan B Massie; Jacqueline M Garonzik-Wang; Dorry L Segev; William A Werbel
Journal:  Transplantation       Date:  2021-12-01       Impact factor: 5.385

7.  BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel.

Authors:  Tal Brosh-Nissimov; Efrat Orenbuch-Harroch; Michal Chowers; Meital Elbaz; Lior Nesher; Michal Stein; Yasmin Maor; Regev Cohen; Khetam Hussein; Miriam Weinberger; Oren Zimhony; Bibiana Chazan; Ronza Najjar; Hiba Zayyad; Galia Rahav; Yonit Wiener-Well
Journal:  Clin Microbiol Infect       Date:  2021-07-07       Impact factor: 8.067
  7 in total
  6 in total

1.  Strong response after 4th dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccine.

Authors:  Nadia E Aikawa; Leonard V K Kupa; Clovis A Silva; Carla G S Saad; Sandra G Pasoto; Emily F N Yuki; Solange R G Fusco; Samuel K Shinjo; Danieli C O Andrade; Percival D Sampaio-Barros; Rosa M R Pereira; Anna C S Chasin; Andrea Y Shimabuco; Ana P Luppino-Assad; Elaine P Leon; Marta H Lopes; Leila Antonangelo; Ana C Medeiros-Ribeiro; Eloisa Bonfa
Journal:  Rheumatology (Oxford)       Date:  2022-05-26       Impact factor: 7.046

2.  Immunogenicity of Inactivated SARS-CoV-2 Vaccines in Patients With Rheumatoid Arthritis: A Case Series.

Authors:  Ting Zhao; Jiayan Shen; Youyang Zhu; Xiaofang Tian; Guangfen Wen; Yuanyuan Wei; Bonan Xu; Chenyang Fu; Zhaohu Xie; Yujiang Xi; Zhenmin Li; Jiangyun Peng; Yang Wu; Xiaohu Tang; Chunping Wan; Lei Pan; Zhaofu Li; Dongdong Qin
Journal:  Front Public Health       Date:  2022-04-25

3.  Fourth dose of COVID-19 vaccine: Does it still contribute any additional immunoprotection?

Authors:  Rujittika Mungmunpuntipantip; Viroj Wiwanitkit
Journal:  J Taibah Univ Med Sci       Date:  2022-04-30

Review 4.  SARS-CoV-2 Omicron variant: recent progress and future perspectives.

Authors:  Yao Fan; Xiang Li; Lei Zhang; Shu Wan; Long Zhang; Fangfang Zhou
Journal:  Signal Transduct Target Ther       Date:  2022-04-28

5.  Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study).

Authors:  Zoltán Kiss; István Wittmann; Lőrinc Polivka; György Surján; Orsolya Surján; Zsófia Barcza; Gergő Attila Molnár; Dávid Nagy; Veronika Müller; Krisztina Bogos; Péter Nagy; István Kenessey; András Wéber; Mihály Pálosi; János Szlávik; Zsuzsa Schaff; Zoltán Szekanecz; Cecília Müller; Miklós Kásler; Zoltán Vokó
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

6.  Safety and immunogenicity of fifth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series.

Authors:  Mayan S Teles; Caoilfhionn M Connolly; Rachel Wallwork; Sarah Frey; Teresa Po-Yu Chiang; Jennifer L Alejo; Jemima Albayda; Lisa Christopher-Stine; Dorry L Segev; William A Werbel; Julie J Paik
Journal:  Rheumatology (Oxford)       Date:  2022-06-27       Impact factor: 7.046
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.